OCGN Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
2.0M
+31.1%
1.5M
-2.9%
1.5M
—
1.8M
Cost of Revenue
0
0
0
0
0
Gross Profit
2.0M
+31.1%
1.5M
-2.9%
1.5M
—
1.8M
Operating Expenses
19.7M
+9.9%
17.9M
-7.4%
19.4M
—
19.4M
R&D
12.5M
+16.9%
10.7M
-5.0%
11.3M
—
11.1M
SG&A
7.2M
-0.5%
7.2M
-10.8%
8.1M
—
8.2M
Operating Income
-17753000
-8.0%
-16444000
+7.8%
-17839000
—
-17625000
EBITDA
-17205000
-8.5%
-15858000
+8.1%
-17249000
-4244.8%
-397000
+97.6%
-16675000
Net Income
-3598000
+85.5%
-24877000
-29.7%
-19177000
—
-20051000
EPS (Basic)
$-0.01
+85.7%
$-0.07
-16.7%
$-0.06
—
$-0.07
EPS (Diluted)
$-0.01
+85.7%
$-0.07
-16.7%
$-0.06
—
$-0.07
Shares (Diluted)
339.2M
+0.2%
338.7M
+3.4%
327.5M
+4.8%
312.6M
+2.8%
304.0M
Ocugen (OCGN) — Financials